Akebia
Akebia Therapeutics
Quick answer
Akebia is a pharma company (AKBA) headquartered in CAMBRIDGE, MA, USA with 24 tracked pipeline programs.
Pipeline (24)
Epoetin alga (Epogen)/vadadustat
Anemia Associated With Chronic Kidney Disease
1 trials projectErythropoiesis-Stimulating Agent (ESA)
Anemia of Chronic Kidney Disease
1 trials projectFerric Citrate 1 GM Oral Tablet [AURYXIA]
Anemia, Iron Deficiency
1 trials projectVadadustat
Anemia
10 trials projectVadadustat
Anemia Associated With Chronic Kidney Disease (CKD)
1 trials projectVadadustat
Anemia of Chronic Kidney Disease
3 trials projectVadadustat 900mg
Nonintubated Acute Respiratory Distress Syndrome (ARDS)
1 trials projectAKB-6548
Anemia
4 trials projectIW-1973
Type 2 Diabetes Mellitus With Diabetic Nephropathy
1 trials projectIW-1973
Heart Failure With Preserved Ejection Fraction
1 trials projectPraliciguat
Focal Segmental Glomerulosclerosis
1 trials projectVadadustat
Chronic Kidney Disease
1 trials projectvadadustat
Acute Respiratory Distress Syndrome
1 trials projectAKB-6548
Healthy Volunteers
1 trials projectAKB-6548 (therapeutic dose)
Healthy Volunteers
1 trials projectAKB-6548 tablet, reference formulation given in the fasted state
Healthy
1 trials projectAKB-9090
Healthy Volunteers
1 trials projectCelecoxib
Healthy Volunteers
1 trials projectVadadustat
Healthy Volunteers
1 trials projectVadadustat
Anemia Associated With Chronic Kidney Disease
1 trials projectVadadustat
Drug Interaction Potentiation
4 trials projectVadadustat
Hepatic Impairment
1 trials projectvadadustat
Healthy
1 trials projectvadadustat reference tablets
Healthy
1 trialsDrugs (1)
Patents (8)
US 12419877
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac
patentUS 11883386
Prolyl hydroxylase inhibitors and methods of use
patentUS 11857543
Compositions and methods for treating anemia
patentUS 11844756
Compositions and methods for treating anemia
patentUS 11690836
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac
patentUS 11524939
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic a
patentUS 11426393
Prolyl hydroxylase inhibitors and methods of use
patentUS 11324734
Compositions and methods for treating anemia